Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage

Department of Neurology, Northwestern University's Feinberg School of Medicine, 710 N Lake Shore Drive, Chicago, IL 60611, USA.

Neurocritical Care. 2010;13((3):):313-20.
BACKGROUND AND PURPOSE In patients with subarachnoid hemorrhage (SAH), higher hemoglobin (HGB) has been associated with better outcomes, but packed red blood cell (PRBC) transfusions with worse outcomes. We performed a prospective pilot trial of goal HGB after SAH. METHODS Forty-four patients with SAH and high risk for vasospasm were randomized to goal HGB concentration of at least 10 or 11. 5 g/dl. We obtained blinded clinical outcomes at 14 days (NIH Stroke Scale and modified Rankin Scale, mRS), 28 days (mRS), and 3 months (mRS), and blinded interpretation of brain MRI for cerebral infarction at 14 days. This trial is registered at www. stroketrials. org. RESULTS Forty-four patients were randomized. Patients with goal HGB 11. 5 g/dl received more PRBC units per transfusion [1 (1-2) vs. 1 (1-1), P < 0. 001] and more total PRBC units [3 (2-4) vs. 2 (1-3), P = 0. 045]. Prospectively defined safety endpoints were not different between groups. HGB concentration was different between study groups from day 4 onwards. The number of cerebral infarctions on MRI (6 of 20 vs. 9 of 22), NIH Stroke Scale scores at 14 days [1 (0-9. 75) vs. 2 (0-16)], and rates of independence on the mRS at 14 days (65% vs. 44%) and 28 days (80% vs. 67%) were similar, but favored higher goal HGB (P > 0. 1 for all). CONCLUSIONS Higher goal hemoglobin in patients with SAH seems to be safe and feasible. A phase III trial of goal HGB after SAH is warranted.
Study details
Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine